{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:07:13Z","timestamp":1757700433005},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1157\/13080266","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T14:44:56Z","timestamp":1131029096000},"page":"551-559","source":"Crossref","is-referenced-by-count":10,"title":["Complicaciones infecciosas asociadas al uso de f\u00e1rmacos antagonistas del factor de necrosis tumoral. Revisi\u00f3n de conjunto"],"prefix":"10.1016","volume":"23","author":[{"given":"Juan M.","family":"Garc\u00eda-Lechuz Moya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13080266_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-76-4-573","article-title":"The prevalence of rheumatoid arthritis: follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts","volume":"76","author":"O'Sullivan","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1157\/13080266_bib2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","article-title":"Long-term outcome of treating rheumatoid arthritis: results after 20 years","volume":"2","author":"Scott","year":"1987","journal-title":"Lancet"},{"key":"10.1157\/13080266_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0025-6196(11)62405-1","article-title":"TNF-alpha inhibition: the need for a tumor necrosis factor thermostat","volume":"76","author":"O\u2019Dell","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1157\/13080266_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/rheumatology\/35.8.781","article-title":"The cost of rheumatoid arthritis","volume":"35","author":"McIntosh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1157\/13080266_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(94)90335-2","article-title":"Signals and signs for lymphocyte responses","volume":"76","author":"Janeway","year":"1994","journal-title":"Cell"},{"key":"10.1157\/13080266_bib6","series-title":"Immunology at a glance","author":"Playfair","year":"1996"},{"key":"10.1157\/13080266_bib7","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2000"},{"key":"10.1157\/13080266_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.iy.10.040192.003021","article-title":"Physiological and molecular mechanisms of lymphocyte homing","volume":"10","author":"Picker","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1157\/13080266_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/322031","article-title":"Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia","volume":"184","author":"Preas","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1157\/13080266_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI2338","article-title":"LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria","volume":"101","author":"Lamping","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1157\/13080266_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfieffer","year":"1993","journal-title":"Cell"},{"key":"10.1157\/13080266_bib12","first-page":"347","article-title":"T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective","volume":"54","author":"Tanaka","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1157\/13080266_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13080266_bib14","first-page":"170","article-title":"New disease modifying agents in adult rheumatoid arthritis","volume":"30","author":"Koh","year":"2001","journal-title":"Ann Acad Med Singapore"},{"key":"10.1157\/13080266_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.59.suppl_1.i46","article-title":"Etanercept (Enbrel\u00ae): update on therapeutic use","volume":"59","author":"Spencer-Green","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13080266_bib16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.1.5.1041","article-title":"Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis","volume":"1","author":"Hamilton","year":"2000","journal-title":"Expert Opin Pharmaco ther"},{"key":"10.1157\/13080266_bib17","first-page":"S139","article-title":"Pharmacokinetics (PK) of etanercept are unaltered by concurrent administration of methotrexate (MTX) in rheumatoid arthritis (RA) (Abstract 253)","volume":"48","author":"Zhou","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.59.6.428","article-title":"Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor-alpha (infliximab) in spondyloarthropathy: an open pilot study","volume":"59","author":"Van den Bosch","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13080266_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1157\/13080266_bib20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","article-title":"Successful treatment of active ankylosing spondylitis with the anti-tumour necrosis factor-alpha monoclonal antibody infliximab","volume":"43","author":"Brandt","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl 4","key":"10.1157\/13080266_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2036.1999.00027.x","article-title":"Review article: safety of infliximab in clinical trials","volume":"13","author":"Hanauer","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13080266_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1157\/13080266_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1157\/13080266_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/75.10.1093","article-title":"Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis","volume":"75","author":"Aboulafia","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1157\/13080266_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0248-8663(00)00238-1","article-title":"Value of anti-TNF-alpha molecules in inflammatory and infectious diseases","volume":"21","author":"Fautrel","year":"2000","journal-title":"Rev Med Interna"},{"key":"10.1157\/13080266_bib26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2165\/00003495-200059060-00010","article-title":"Infliximab: a review of its use in the management of rheumatoid arthritis","volume":"59","author":"Markham","year":"2000","journal-title":"Drugs"},{"key":"10.1157\/13080266_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO;2-H","article-title":"Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes","volume":"50","author":"Raza","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1157\/13080266_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","article-title":"Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib29","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelinizating effects of etanercept therapy","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(91)90051-Z","article-title":"The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis","volume":"21","author":"Caldwell","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1157\/13080266_bib31","first-page":"1257","article-title":"Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia","volume":"18","author":"Lang","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1157\/13080266_bib32","first-page":"84","article-title":"Prevention of infections related to anti-TNF treatments","volume":"28","author":"Bouza","year":"2001","journal-title":"Rev Esp Reumatol"},{"key":"10.1157\/13080266_bib33","first-page":"59","article-title":"Infectious complications in rheumatoid arthritis","volume":"200","author":"Garc\u00eda-Lechuz","year":"2000","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13080266_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.150.1.8025760","article-title":"Opportunistic infection during treatment with low dose methotrexate","volume":"150","author":"Le Mense","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13080266_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/IAI.65.1.298-304.1997","article-title":"Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis","volume":"65","author":"Keane","year":"1997","journal-title":"Infect Immun"},{"key":"10.1157\/13080266_bib36","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","article-title":"Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology","volume":"69","author":"Mohan","year":"2001","journal-title":"Infect Immun"},{"key":"10.1157\/13080266_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"10.1157\/13080266_bib38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.164.4.2016","article-title":"Virulent Mycobacterium tuberculosis strains eva de apoptosis of infected alveolar macrophages","volume":"164","author":"Keane","year":"2000","journal-title":"J Immunol"},{"key":"10.1157\/13080266_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-84-3-261","article-title":"The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treatment asthmatic population","volume":"84","author":"Schatz","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1157\/13080266_bib40","first-page":"9","article-title":"Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population","volume":"16","author":"Kim","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1157\/13080266_bib41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13080266_bib42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13080266_bib43","unstructured":"FDA Meeting March 2003: update on the safety of new drugs for rheumatoid arthritis Part II: safety and Efficacy Update on TNF alpha inhibitors; Humira (adalimumab), Remicade (infliximab) and Enbrel (etanercept). Washington DC, March 4, 2003; p. 2-233. Disponible en: www.fda.gov\/OHRMS\/DOCKETS\/98fr\/03-4350.html"},{"key":"10.1157\/13080266_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","article-title":"Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor","volume":"39","author":"Mohan","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13080266_bib45","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.67.7.3571-3579.1999","article-title":"Fatal granuloma necrosis without exacerbated mycobacterial growth in TNF receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium","volume":"67","author":"Ehlers","year":"1999","journal-title":"Infect Immun"},{"key":"10.1157\/13080266_bib46","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/labinvest.3780094","article-title":"Correc tion of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation","volume":"80","author":"Jacobs","year":"2000","journal-title":"Lab Invest"},{"key":"10.1157\/13080266_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propia T lymphocytes in Cronh's disease","volume":"50","author":"Ten Hove","year":"2002","journal-title":"Gut"},{"key":"10.1157\/13080266_bib48","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor-\u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1157\/13080266_bib49","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.1830271215","article-title":"High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-\u03b3 in the differentiation of protective granulomas","volume":"27","author":"Garc\u00eda","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1157\/13080266_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alfa monoclonal antibody cA2 binds recombinant transmembrane TNF-alfa and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1157\/13080266_bib51","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1157\/13080266_bib52","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13080266_bib53","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib54","first-page":"S1980","article-title":"54-week clinical and radiographic results from the ATTRACT trial: a phase III study of infliximab (Remicade\u00ae) in patients with active rheumatoid arthritis despite methotrexate","volume":"42","author":"Lipsky","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib55","first-page":"763","article-title":"Rhabdo myolysis and aggravation of arthritis in a rheumatoid arthritis patient as a result of sepsis due to Staphylococcus aureus infection of a rheumatoid nodule; a catastrophic outcome","volume":"342","author":"Saito","year":"1999","journal-title":"J Med Sci"},{"key":"10.1157\/13080266_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4065\/76.6.653","article-title":"Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept","volume":"76","author":"Baghai","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1157\/13080266_bib57","first-page":"61","article-title":"Influencia del infliximab en la resistencia antimicrobiana","volume":"1","author":"P\u00e9rez-Garc\u00eda","year":"2002","journal-title":"Rev Esp Reumatol"},{"key":"10.1157\/13080266_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/thorax.56.2.121","article-title":"Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia","volume":"56","author":"Kolling","year":"2001","journal-title":"Thorax"},{"key":"10.1157\/13080266_bib59","first-page":"1254","article-title":"Pneumocystis carinii pneumoniae associated with methotrexate therapy in rheumatoid arthritis","volume":"18","author":"Flood","year":"1991","journal-title":"J Rheumatol (Canada)"},{"key":"10.1157\/13080266_bib60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/thx.47.8.628","article-title":"Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports","volume":"47","author":"Hargreaves","year":"1992","journal-title":"Thorax"},{"key":"10.1157\/13080266_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF02238967","article-title":"Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature","volume":"16","author":"Salaffi","year":"1997","journal-title":"Clin Rheumatol (Belgium)"},{"issue":"Suppl C","key":"10.1157\/13080266_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2000\/513130","article-title":"Steroid-dependent Crohn's disease","volume":"14","author":"Sandborn","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1157\/13080266_bib63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","article-title":"Does administration of infliximab increase susceptibility to listeriosis?","volume":"95","author":"Morelli","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13080266_bib64","first-page":"S1979","article-title":"Long-term follow-up of patients treated with infliximab (anti-TNF antibody) in clinical trials","volume":"42","author":"Kavanaugh","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13080266_bib65","first-page":"453","article-title":"Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases","volume":"63","author":"Roux","year":"1996","journal-title":"Rev Rheum Engl Ed"},{"key":"10.1157\/13080266_bib66","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13080266_bib67","first-page":"15","article-title":"Poor wound healing following surgery in three patients who received infliximab for Crohn's disease","author":"Griffin","year":"2000","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05750278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05750278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:08:15Z","timestamp":1586538495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X05750278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0213005X05750278"],"URL":"https:\/\/doi.org\/10.1157\/13080266","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}